Flexicare is a leading manufacturer, designing innovative airway management & respiratory medical devices, with over 35 years experience. We help patients and clinicians to breathe easier. Our expansive product range includes our ProVu video laryngoscope range, anesthesia breathing systems and accessories, breathing filters, resuscitation devices with support materials for hospital environments. Flexicare is committed to protecting what matters most: patients, clinicians, hospitals.
Endo-Therapeutics, Inc.
Endo-Therapeutics, based in Clearwater, FL, is a leading medical device manufacturer with over 30 years of experience specializing in the design and development of single-use endoscopic devices. As one of the top domestic producers of biopsy forceps and polypectomy snares in the US, we are proud to deliver millions of single-use devices worldwide. We’ve recently expanded into the pulmonology market—our pulmonology products include Single-use Flexible Bronchoscopes, BioCeps Biopsy Forceps, and the EndoTBrush Cytology Brush.
DELFI Diagnostics
DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI platform is built to address the highest-burden health challenges. We prioritize solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI’s platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. For more information, visit www.delfidiagnostics.com. | DELFI Diagnostics is developing next-generation, blood-based tests that are accurate, accessible, and deliver a new way to help detect cancer. DELFI tests are built to solve the highest-burden population health issues, including in historically underserved demographics, and have the potential to save lives on a global scale. FirstLook Lung, for individuals eligible for lung cancer screening, is our first laboratory-developed screening test and requires a simple blood draw that can be incorporated with routine blood work. The test is based on fragmentomics, the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments in the blood. The DELFI platform applies advanced machine-learning technology to whole-genome sequencing data to assess individuals’ cfDNA fragments against populations with and without cancer. FirstLook Lung uses these millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early-stage disease, with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA. To learn more about the FirstLook Lung test, visit www.delfidiagnostics.com or www.firstlooktest.com.
Coreline North America, Inc
Coreline North America Inc. is a forward thinking innovator in the Chest CT based AI space. We provide automatic quantitative results in COPD, Lung Nodule Detection, Interstitial Lung Disease, Cardiac Scoring, and many more areas.
COOK MEDICAL
Cook Medical invents, manufactures and delivers a unique portfolio of medical devices to healthcare systems around the world. We demand the highest standards of quality, ethics and service. Since 1963, we have remained family owned so we can focus on what we care about: patients, our employees and our communities.
CognomIQ
You’ve spent millions chasing clean data—and still wait months for answers. How much longer will you fund dysfunction? CognomIQ eliminates vendor sprawl with healthcare’s only provider-owned data OS, unifying 200+ sources into one trusted truth. Make faster, fact-based decisions and redirect OpEx from complexity to strategy—with ROI in under a year.